CELG-RI(CELG-RI)
CELG-RI
No analyst ratings available
No analyst price targets available for CELG-RI
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $47.30B | $46.32B | $40.95B | $37.52B | $36.79B |
| Low | $47.30B | $46.32B | $40.95B | $37.52B | $36.79B |
| High | $47.30B | $46.32B | $40.95B | $37.52B | $36.79B |
| EBITDA Avg | $16.51B | $16.17B | $14.29B | $13.10B | $12.84B |
| Low | $16.51B | $16.17B | $14.29B | $13.10B | $12.84B |
| High | $16.51B | $16.17B | $14.29B | $13.10B | $12.84B |
| EBIT Avg | $7.48B | $7.33B | $6.48B | $5.94B | $5.82B |
| Low | $7.48B | $7.33B | $6.48B | $5.94B | $5.82B |
| High | $7.48B | $7.33B | $6.48B | $5.94B | $5.82B |
| Net Income Avg | $12.88B | $12.56B | $11.01B | $9.89B | $9.75B |
| Low | $12.88B | $12.56B | $11.01B | $9.89B | $9.75B |
| High | $12.88B | $12.56B | $11.01B | $9.89B | $9.75B |
| EPS Avg | $6.32 | $6.16 | $5.40 | $4.85 | $4.78 |
| Low | $6.32 | $6.16 | $5.40 | $4.85 | $4.78 |
| High | $6.32 | $6.16 | $5.40 | $4.85 | $4.78 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $12.02B | $12.10B | $10.91B | $11.43B | $11.60B | $12.05B | $9.92B | $10.18B |
| Low | $12.02B | $12.10B | $10.91B | $11.43B | $11.60B | $12.05B | $9.92B | $10.18B |
| High | $12.02B | $12.10B | $10.91B | $11.43B | $11.60B | $12.05B | $9.92B | $10.18B |
| EBITDA Avg | $4.20B | $4.22B | $3.81B | $3.99B | $4.05B | $4.21B | $3.46B | $3.55B |
| Low | $4.20B | $4.22B | $3.81B | $3.99B | $4.05B | $4.21B | $3.46B | $3.55B |
| High | $4.20B | $4.22B | $3.81B | $3.99B | $4.05B | $4.21B | $3.46B | $3.55B |
| EBIT Avg | $1.90B | $1.91B | $1.73B | $1.81B | $1.84B | $1.91B | $1.57B | $1.61B |
| Low | $1.90B | $1.91B | $1.73B | $1.81B | $1.84B | $1.91B | $1.57B | $1.61B |
| High | $1.90B | $1.91B | $1.73B | $1.81B | $1.84B | $1.91B | $1.57B | $1.61B |
| Net Income Avg | $3.28B | $3.12B | $2.83B | $3.17B | $3.14B | $3.16B | $2.47B | $2.68B |
| Low | $3.28B | $3.12B | $2.83B | $3.17B | $3.14B | $3.16B | $2.47B | $2.68B |
| High | $3.28B | $3.12B | $2.83B | $3.17B | $3.14B | $3.16B | $2.47B | $2.68B |
| EPS Avg | $1.60 | $1.52 | $1.38 | $1.55 | $1.53 | $1.54 | $1.21 | $1.31 |
| Low | $1.60 | $1.52 | $1.38 | $1.55 | $1.53 | $1.54 | $1.21 | $1.31 |
| High | $1.60 | $1.52 | $1.38 | $1.55 | $1.53 | $1.54 | $1.21 | $1.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |